Leadership Team
Sujuan Ba, Ph.D
Co-Founder & Chief Executive Officer
Kwok Leung, Ph.D.
Chief Financial Officer
Brian Leyland-Jones, MBBS, Ph.D.
Chief Medical Officer
Rose Wang, MBA
Executive Advisor
Ella Ye
Program Coordinator
Board of Directors
Charlie Weatherspoon
Chairman and Co-founder
Matt Tremblay, Ph.D.
Vice Chairman
Franklin Salisbury, Jr.
Co-founder and Director
Mark Baran
Director
Brian Leyland-Jones, MBBS, Ph.D.
Chief Medical Officer
Alfred Slanetz, Ph.D.
Director
Yajun Xu, Ph.D.
Director
Strategic Advisors
Webster K. Cavenee, Ph.D.
Director of Strategic Alliances, Ludwig Institute for Cancer Research
Pamela Garzone, Ph.D.
Chief Development Officer, Anixa Biosciences
Chih-Kao Hu, Ph.D., MBA
Management Consultant, Qral Group
Lance Kawaguchi
Chief Executive Officer, Cure Brain Cancer Foundation
Raju Kucherlapati, Ph.D.
Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
Lou Lieto, Ph.D., J.D.
Partner, Wilson Sonsini
Jimmy Lu, J.D., MBA
Co-Founder & Managing Director, Eos BioInnovation
Patty Obermaier
Vice President, US Health and Life Sciences, Microsoft
Program Advisors
Monica Bertagnolli, M.D.
Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School
Carlo M. Croce, M.D.
Professor of Internal Medicine, The Ohio State University
Aleksandra Filipovic, M.D., Ph.D.
Head of Oncology, PureTech Health
Dimitra Georganopoulou, Ph.D.
General Partner, Qral Ventures
Jennifer Grandis, M.D.
American Cancer Society Professor, University of California San Francisco
Kim Kamdar, Ph.D.
Managing Partner, Medical Excellence Capital
Scott Lippman, M.D.
Director, Moores Cancer Center, UC San Diego Health
Beverly Lu, Ph.D.
Investment Manager, Health, Emerson Collective
Amy Millman
President & Co-Founder, Springboard Enterprises
Eifion Phillips, Ph.D., J.D.
Patent Attorney
Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore
Michael Salgaller, Ph.D.
Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute
Paul Schimmel, Ph.D.
Professor, Department of Cell and Molecular Biology, The Scripps Research Institute
Fei Shen, Ph.D.
Managing Director, Boehringer Ingelheim Venture Fund USA
Thea Tlsty, Ph.D.
Professor of Pathology, University of California San Francisco
Daniel D. Von Hoff M.D., F.A.C.P.
Physician-in-Chief & Distinguished Professor, Translational Genomics Research Institute
Barbara Weber, M.D.
President & CEO, Tango Therapeutics